Chapter 20 Health Alt Flashcards
Significantly altered hormone levels due to:
-Inappropriate amounts of hormone delivered to target cell
->Disorders of endocrine glands
->Failure of feedback systems
->Dysfunctional hormones
->Defects in hormone delivery
-Inappropriate responses by the target cell
->Abnormalities in receptors
->Intracellular disorders
Alterations of the Hypothalamic-Pituitary System
-The most common cause of apparent hypothalamic dysfunction is interruption of the pituitary stalk. Such interruptions prevent hypothalamic hormones from reaching the pituitary gland.
-Damage to the pituitary stalk can be caused by destructive lesions, rupture after head injury, surgical transection, or tumor.
-Without hypothalamic hormones, the pituitary releases inadequate amounts of follicle-stimulating hormone (FSH), luteinizing hormone (LH), adrenocorticotropic hormone (ACTH), thyroid stimulating hormone (TSH), and growth hormone.
Diseases of the Posterior Pituitary: Part 1
-Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
->Hypersecretion of ADH
->Caused by ectopic production of ADH by tumors (in the lungs, stomach, pancreas, bladder, etc.), pulmonary (pneumonia, asthma, cystic fibrosis, etc.) or CNS disorders (encephalitis, meningitis, tumors, & trauma), surgery, or medications (can happen a lot in the elderly)
->Clinical manifestations are related to hyponatremia and are determined by severity
Symptoms of SIADH:
-enhanced renal free water retention
-hyponatremia
-GI symptoms include vomiting, abdominal cramps
Diseases of the Posterior Pituitary: Part 2
-Diabetes insipidus (DI)
->Insufficiency of ADH causing loss of too much water in urine
->Two forms
->Neurogenic (central)—insufficient secretion of ADH
->Nephrogenic—inadequate response to ADH
->Manifestations include polyuria, nocturia, and continuous thirst
Diabetes insipidus
insufficient ADH activity
1.Neurogenicorcentral DI.Caused by the insufficient secretion of ADH, it occurs when any organic lesion of the hypothalamus, pituitary stalk, or posterior pituitary interferes with ADH synthesis, transport, or release. Causative lesions include primary brain tumors, traumatic brain injury, hypophysectomy, aneurysms, thrombosis, infections, and immunologic disorders. It can also be caused by hereditary disorders that affect ADH genes or result in structural changes in the pituitary gland.
2.Nephrogenic DI.Caused by inadequate response of the renal tubules to ADH. Acquired nephrogenic DI is caused by disorders and drugs that damage the renal tubules. These disorders include pyelonephritis, amyloidosis, destructive uropathies, and polycystic kidney disease. Drugs that may induce a reversible form of nephrogenic DI include lithium carbonate, colchicine, amphotericin B, loop diuretics, general anesthetics, and demeclocycline.
-Individuals with DI have a partial to total inability to concentrate urine.
-Insufficient ADH activity causes excretion of large volumes of dilute urine, leading to increased plasma osmolality.
-In conscious individuals, the thirst mechanism is stimulated and induces polydipsia.
-Dehydration develops rapidly without ongoing fluid replacement.
-The clinical manifestations of DI include polyuria, nocturia, continuous thirst, and polydipsia.
Diseases of the Anterior Pituitary: Part 1; Hypopituitarism
-Hypopituitarism
->Absence or failure of anterior pituitary hormones
->Panhypopituitarism—all hormones deficient and the person suffers from multiple complications
-Caused by
->Pituitary infarction (may occur when there is significant blood loss or hypovolemic shock. OR in women during the postpartum period (Sheehan syndrome) )
->Space-occupying lesions (include pituitary adenomas or aneurysms, which can enlarge and compress the pituitary gland)
->Traumatic brain injury
->Removal of destruction of the gland
->Infections (meningitis, syphilis, etc.)
->Autoimmune hypophysitis
-Symptoms related to cortisol insufficiency
Anterior pituitary - Panhypopituitarism; the certain deficiencies.
-ACTH deficiency with associated loss of cortisol is a potentially life-threatening disorder.
-Symptoms of cortisol insufficiency include nausea, vomiting, anorexia, fatigue, and weakness.
-TSH deficiency causes cold intolerance, skin dryness, lethargy, and decreased metabolic rate. -The onset of FSH and LH deficiencies in women of reproductive age is associated with amenorrhea and atrophy of the vagina, uterus, and breasts.
-GH deficiency in children is manifested by growth failure and a condition known ashypopituitary dwarfism.
Diseases of the Anterior Pituitary: Part 2; Hyperpituitarism
-Hypersecretion of hormones
-Commonly caused by a benign, slow-growing pituitary adenoma
-Manifestations related to tumor growth and hormone hyper/hyposecretion
Diseases of the Anterior Pituitary: Part 3; Hypersecretion of growth hormone (GH)
-Acromegaly
->Hypersecretion of GH during adulthood
-Giantism
->Hypersecretion of GH in children whose epiphyseal plates have not yet closed
Diseases of the Anterior Pituitary: Part 4; Prolactinoma
-Prolactinoma
->Hypersecretion of prolactin
->Caused by pituitary tumors that secrete prolactin
-Manifestations
->In females, amenorrhea, galactorrhea, hirsutism, and osteopenia
->In males, gynecomastia, hypogonadism, and erectile dysfunction
Alterations to the Thyroid Function: Part 1
-Primary thyroid disorders
->Dysfunction or disease of thyroid
->Increased or decreased thyroid hormone (TH)
->Idiopathic, caused by autoimmune mechanisms
-Central (secondary) thyroid disorders
->Disorders of pituitary gland thyroid stimulating hormone (TSH) production
Alterations to the Thyroid Function: Part 2
-Thyrotoxicosis
->Condition due to any cause of increased TH levels
->Hyperthyroidism—increased TH levels from thyroid gland
->Primary caused by Graves disease, toxic multinodular goiter, and solitary toxic adenoma
->Central (secondary) caused by pituitary adenomas
->Manifestations are increased metabolic rate, heat intolerance, and tissue sensitivity
Alterations to the Thyroid Function: Part 3
Hyperthyroid conditions
->Graves disease
->Autoimmune disease caused by stimulation of thyroid by autoantibodies against TSH receptor
->Pretibial myxedema
->Hyperthyroidism resulting from nodular thyroid disease
->Toxic multinodular goiter
->Toxic adenoma
->Thyrotoxic crisis (thyroid storm)
->TH levels rise dramatically, can be fatal
Alterations to the Thyroid Function: Part 4
Hypothyroidism
->Deficient production of TH by thyroid gland
->Primary
->Loss of thyroid function
->Caused by autoimmune thyroiditis, loss of thyroid tissue, medications, and endemic iodine deficiency
->Central (secondary)
->Failure of pituitary to synthesize adequate TSH
->Caused by pituitary tumors and associated treatments
->Manifestations are decreased metabolic rate, cold intolerance, and lethargy
Alterations to the Thyroid Function: Part 5
Hypothyroid conditions
->Hashimoto disease
->Autoimmune (thyroiditis) disease causing gradual destruction of thyroid tissue
->Congenital hypothyroidism
->Thyroid tissue absent
->Hereditary defects in TH synthesis
->Subacute thyroiditis (de Quervain thyroiditis)
->is a rare nonbacterial inflammation of the thyroid gland often preceded by a viral infection. It is accompanied by fever, tenderness, and enlargement of the thyroid gland and transient hypothyroidism before the gland recovers normal activity.
->Postpartum thyroiditis
->generally occurs up to 6 months after birthing with a course similar to that seen in subacute thyroiditis.
->Iatrogenic hypothyroidismresults from ablation of the thyroid gland during treatment for hyperthyroid conditions.
Thyroid Carcinoma
-Most common endocrine malignancy
->Exposure to ionizing radiation, especially during childhood, is the most consistent causal factor. Papillary and follicular thyroid carcinomas are the most frequent, and medullary and anaplastic thyroid carcinomas are less common. The cancer is typically discovered as a small thyroid nodule or metastatic tumor in the lungs, brain, or bone.
-Ionizing radiation most common cause
-Treated with thyroidectomy, suppression therapy, radiation, and chemotherapy
Alterations of Parathyroid Function: Part 1
Hyperparathyroidism
->Increased secretion of parathyroid hormone (PTH)
->Classified as:
->Primary— excess secretion of PTH from one or more parathyroid glands
->Secondary—increase in PTH secondary to chronic hypocalcemia; parathyroid glands to chronic hypocalcemia, which is commonly associated with decreased activation of vitamin D in individuals with renal failure. caused by renal disease.
->Tertiary—develops after a long period of hypocalcemia; such as is seen with chronic dialysis, renal transplantation, or gastrointestinal malabsorption.
->Hallmark manifestations are hypercalcemia and hypophosphatemia
-(PTH hypersecretion enhances renal phosphate excretion and results in hypophosphatemia and hyperphosphaturia)
Alterations of Parathyroid Function: Part 2
Hypoparathyroidism
->Abnormally low PTH levels
->Usually caused by parathyroid damage in thyroid surgery.
->Hypomagnesemia is another cause of low PTH levels bc it inhibits PTH secretion.
->Manifestations are primarily those of hypocalcemia.
Hypercalcemia
-Hypercalcemia means that the renal tubules must filter large amounts of calcium, leading to hypercalciuria and production of an abnormally alkaline urine.
-its when there in an abnormally high amount of calcium in the blood
Diabetes Mellitus Type 1
Type 1 diabetes (caused by autoimmune beta-cell destruction, usually leading to absolute insulin deficiency)
->Idiopathic Type1: Idiopathic type 1 diabetes mellitusis far less common than autoimmune diabetes, has a strong genetic component, and occurs mostly in people of Asian or African descent. Affected individuals have no evidence of beta-cell autoimmunity and have varying degrees of insulin deficiency.
->Autoimmune Type 1: Autoimmune type 1 diabetes mellitusis a slowly progressive disease that destroys beta cells of the pancreas. There are strong genetic associations with histocompatibility leukocyte antigen (HLA) class II allelesHLA-DQandHLA-DR.
->Immunologically mediated Beta cell destruction and apoptosis
80%-90% cells lost, insulin synthesis declines, hyperglycemia develops
->Alterations in insulin, amylin, glucagon
->Insulin normally suppresses secretion of glucagon, and thus hypoinsulinemia leads to a marked increase in glucagon secretion. In addition to the decline in insulin secretion, there is decreased secretion ofamylin(another beta-cell hormone), which also leads to an increase in glucagon.Glucagon,a hormone produced by the alpha cells of the islets, acts in the liver to increase the blood glucose level by stimulating glycogenolysis and gluconeogenesis.. Thus both a lack of insulin and a relative excess of glucagon contribute to hyperglycemia in type 1 diabetes.
Type 1 Diabetes Mellitus Clinical Manifestations
Manifestations result from insulin deficiency:
->Hyperglycemia
->Polydipsia (inc thirst)
->Polyuria (inc urination)
->Polyphagia (inc hunger)
->Weight loss
->Fatigue
->Recurrent infections
->Prolonged wound healing
-The common clinical manifestations of type 1 diabetes result from both insulin deficiency and hyperglycemia. Acute complications also may include hypoglycemia and DKA. Chronic complications include renal, nervous system, cardiac, peripheral vascular, retinal, and bony tissue dysfunction.
Diabetes Mellitus Type 2
Type 2 diabetes (caused by progressive loss of beta-cell insulin secretion, frequently with a background of insulin resistance)
-Initial insulin resistance
->Compensatory hyperinsulinemia prevents clinical appearance
->A decrease in beta-cell mass and a reduction in normal beta-cell function develops and leads to a relative deficiency of insulin activity. The glucagon concentration is increased in type 2 diabetes because pancreatic alpha cells become less responsive to glucose inhibition, resulting in an increase in glucagon secretion.
-Later loss of beta cells causing deficiency of insulin activity
-GI hormones play role in insulin resistance
->Hormones released from the gastrointestinal (GI) tract play a role in insulin resistance, beta-cell function, and diabetes.Ghrelinis a peptide produced in the stomach and pancreatic islets that regulates food intake, energy balance, and hormonal secretion. Theincretinsare a class of peptides that are released from the GI tract in response to food intake and function to increase the secretion of insulin and have many other positive effects on metabolism.
Type 2 Diabetes Mellitus: Manifestations and risk factors
-Genetic abnormalities combined with environmental influences result in the basic pathophysiologic mechanisms of type 2 diabetes, which are insulin resistance and decreased insulin secretion by beta cells. The most well-recognized risk factors are family history, age, obesity, hypertension, poor diet, and physical inactivity.
-Obesity is one of the most important contributors to insulin resistance and diabetes
-Manifestations (nonspecific): fatigue, pruritus, recurrent infections, visual changes, or symptoms of neuropathy; often overweight, dyslipidemic, and hypertensive
-3 P’s as well
-The metabolic syndrome is a constellation of disorders (central obesity, dyslipidemia, prehypertension, and an elevated FBG) that together confer a high risk of developing type 2 diabetes and associated cardiovascular complications.
Gestational Diabetes Mellitus
-Gestational diabetes mellitus (GDM) (diabetes diagnosed in the second or third trimester of pregnancy that was not clearly overt diabetes prior to gestation)
-Gestational diabetes mellitus (GDM)
->Any degree of glucose intolerance with onset or first recognition during pregnancy
-Maturity onset diabetes of youth (MODY)
->Beta-cell function or insulin action affected by autosomal dominant mutations